IN2012DN03130A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN03130A IN2012DN03130A IN3130DEN2012A IN2012DN03130A IN 2012DN03130 A IN2012DN03130 A IN 2012DN03130A IN 3130DEN2012 A IN3130DEN2012 A IN 3130DEN2012A IN 2012DN03130 A IN2012DN03130 A IN 2012DN03130A
- Authority
- IN
- India
- Prior art keywords
- propofol
- compositions
- aerosols
- buccal
- capsules
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C19/00—Acyclic saturated compounds containing halogen atoms
- C07C19/08—Acyclic saturated compounds containing halogen atoms containing fluorine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention provides novel pharmaceutical compositions comprising the active ingredient propofol. Preferably, propofol is dissolved in at least one semifluorinated alkane. The compositions, which are preferably liquid or gel-like, may optionally comprise further excipients. They may be used as fill material in capsules, as buccal or nasal sprays, or as aerosols for pulmonary administration. They are particularly useful for the transmucosal administration of propofol.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09014548A EP2332525A1 (en) | 2009-11-23 | 2009-11-23 | Pharmaceutical composition comprising propofol |
| PCT/EP2010/067938 WO2011061332A1 (en) | 2009-11-23 | 2010-11-22 | Pharmaceutical composition comprising propofol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN03130A true IN2012DN03130A (en) | 2015-09-18 |
Family
ID=41694756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3130DEN2012 IN2012DN03130A (en) | 2009-11-23 | 2010-11-22 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8796340B2 (en) |
| EP (2) | EP2332525A1 (en) |
| JP (1) | JP5707009B2 (en) |
| KR (1) | KR20120104262A (en) |
| CN (1) | CN102753159B (en) |
| AU (1) | AU2010320823B2 (en) |
| BR (1) | BR112012012108A2 (en) |
| CA (1) | CA2776855C (en) |
| ES (1) | ES2450423T3 (en) |
| IN (1) | IN2012DN03130A (en) |
| MX (1) | MX2012005881A (en) |
| WO (1) | WO2011061332A1 (en) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011113855A2 (en) | 2010-03-17 | 2011-09-22 | Novaliq Gmbh | Pharmaceutical composition for treatment of increased intraocular pressure |
| EP2444063A1 (en) | 2010-10-20 | 2012-04-25 | Novaliq GmbH | Liquid pharmaceutical compositions for the delivery of active ingredients |
| EP2462921A1 (en) | 2010-11-11 | 2012-06-13 | Novaliq GmbH | Liquid pharmaceutical compositions for the treatment of a posterior eye disease |
| DK2714008T3 (en) | 2011-05-25 | 2017-03-13 | Novaliq Gmbh | PHARMACEUTICAL COMPOSITION FOR APPLICATION ON NAIL |
| ES2623233T3 (en) | 2011-05-25 | 2017-07-10 | Novaliq Gmbh | Topical pharmaceutical composition based on semi-fluorinated alkanes |
| GB201116271D0 (en) | 2011-09-21 | 2011-11-02 | Univ Cardiff | Dispersion anaesthetic device |
| KR101989648B1 (en) | 2012-01-23 | 2019-06-14 | 노바리크 게엠베하 | Stabilised protein compositions based on semifluorinated alkanes |
| PL3488847T3 (en) | 2012-09-12 | 2024-04-08 | Novaliq Gmbh | Semifluorinated alkane compositions |
| PT2708228T (en) * | 2012-09-12 | 2018-10-09 | Novaliq Gmbh | Eye wash compositions |
| EP3100722B1 (en) | 2012-09-12 | 2024-03-20 | Novaliq GmbH | Semifluorinated alkanes for use in solubilizing meibum |
| US10273298B2 (en) | 2013-07-23 | 2019-04-30 | Novaliq Gmbh | Stabilized antibody compositions |
| EP2944324A1 (en) * | 2014-05-13 | 2015-11-18 | LTS LOHMANN Therapie-Systeme AG | Use of semifluorinated alkanes in transdermal therapeutic systems |
| WO2016061538A1 (en) | 2014-10-16 | 2016-04-21 | The Board Of Trustees Of The Leland Stanford Junior University | Novel methods, compounds, and compositions for anesthesia |
| ES2803248T3 (en) | 2015-09-30 | 2021-01-25 | Novaliq Gmbh | 2-perfluorohexyl octane for ophthalmic administration |
| CN120884568A (en) | 2015-09-30 | 2025-11-04 | 诺瓦利克有限责任公司 | semifluorinated compounds and their compositions |
| KR102257916B1 (en) | 2016-06-23 | 2021-05-28 | 노바리크 게엠베하 | Kit including drop dispenser |
| JP7012075B2 (en) | 2016-09-22 | 2022-01-27 | ノバリック ゲーエムベーハー | Pharmaceutical composition for use in the treatment of blepharitis |
| CN109906085B (en) | 2016-09-23 | 2024-03-08 | 诺瓦利克有限责任公司 | Ophthalmic compositions containing cyclosporine |
| CN110267645A (en) | 2016-12-23 | 2019-09-20 | 诺瓦利克有限责任公司 | Ophthalmic compositions for the treatment of dry eye |
| WO2018193093A1 (en) | 2017-04-21 | 2018-10-25 | Novaliq Gmbh | Iodine compositions |
| EP3621601A1 (en) | 2017-05-12 | 2020-03-18 | Novaliq GmbH | Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions |
| WO2019063551A1 (en) | 2017-09-27 | 2019-04-04 | Novaliq Gmbh | Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases |
| WO2019068763A1 (en) | 2017-10-04 | 2019-04-11 | Novaliq Gmbh | Ophthalmic compositions comprising f6h8 |
| KR20200128407A (en) | 2018-03-02 | 2020-11-12 | 노바리크 게엠베하 | Pharmaceutical composition containing nebivolol |
| JP2021522219A (en) | 2018-04-27 | 2021-08-30 | ノバリック ゲーエムベーハー | Ophthalmic composition containing tafluprost for the treatment of glaucoma |
| EP3856124A1 (en) | 2018-09-27 | 2021-08-04 | Novaliq GmbH | Lipid barrier repair |
| AU2019358249B2 (en) | 2018-10-12 | 2024-02-22 | Novaliq Gmbh | Ophthalmic composition for treatment of dry eye disease |
| US12397039B2 (en) | 2019-02-13 | 2025-08-26 | Novaliq Gmbh | Compositions and methods for the treatment of ocular neovascularization |
| CA3149046A1 (en) | 2019-09-06 | 2021-03-11 | Jorg Haisser | Ophthalmic composition for the treatment of uveitis |
| EP3912622A1 (en) | 2020-05-19 | 2021-11-24 | tesa Labtec GmbH | Oral film for safe administration of api |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5496537A (en) * | 1995-03-23 | 1996-03-05 | Henry; Richard A. | Propofol hydrofluorocarbon propellant formulations |
| DE19536504C2 (en) * | 1995-09-29 | 1999-09-23 | H Meinert | Use of fluorinated alkanes |
| EP1124416A1 (en) * | 1999-03-15 | 2001-08-22 | John Claude Krusz | Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages |
| GB0124071D0 (en) * | 2001-10-08 | 2001-11-28 | Kbig Ltd | Improvement in the administration of high boiling point aneasthetics |
| CA2549524A1 (en) * | 2004-01-02 | 2005-07-28 | Wisconsin Alumni Research Foundation | Encapsulation of chemical compounds in fluorous-core and fluorous-inner-shell micelles formed from semifluorinated-block or fluorinated-block copolymers |
| DE102004030044A1 (en) | 2004-06-22 | 2006-01-12 | Birken Gmbh | Triterpene-containing oleogel, triterpene-containing oleogel and process for the preparation of a triterpenhaltigen oleogel |
| EP2099408B1 (en) * | 2006-11-28 | 2016-10-05 | Wisconsin Alumni Research Foundation | Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics |
| EP2110126B9 (en) * | 2008-04-18 | 2012-09-19 | Novaliq GmbH | Inhalative and instillative use of semi-fluorised alkanes as active ingredient carriers in the intrapulmonary area |
-
2009
- 2009-11-23 EP EP09014548A patent/EP2332525A1/en not_active Withdrawn
-
2010
- 2010-11-22 AU AU2010320823A patent/AU2010320823B2/en active Active
- 2010-11-22 KR KR1020127016348A patent/KR20120104262A/en not_active Withdrawn
- 2010-11-22 EP EP10778677.4A patent/EP2503999B1/en active Active
- 2010-11-22 BR BR112012012108A patent/BR112012012108A2/en not_active Application Discontinuation
- 2010-11-22 IN IN3130DEN2012 patent/IN2012DN03130A/en unknown
- 2010-11-22 US US13/511,184 patent/US8796340B2/en active Active
- 2010-11-22 WO PCT/EP2010/067938 patent/WO2011061332A1/en not_active Ceased
- 2010-11-22 CA CA2776855A patent/CA2776855C/en active Active
- 2010-11-22 CN CN201080052400.7A patent/CN102753159B/en active Active
- 2010-11-22 MX MX2012005881A patent/MX2012005881A/en not_active Application Discontinuation
- 2010-11-22 JP JP2012539355A patent/JP5707009B2/en active Active
- 2010-11-22 ES ES10778677.4T patent/ES2450423T3/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2450423T3 (en) | 2014-03-24 |
| CA2776855C (en) | 2017-10-24 |
| AU2010320823B2 (en) | 2014-06-26 |
| EP2503999B1 (en) | 2013-12-25 |
| BR112012012108A2 (en) | 2016-04-05 |
| EP2503999A1 (en) | 2012-10-03 |
| CN102753159A (en) | 2012-10-24 |
| US8796340B2 (en) | 2014-08-05 |
| CA2776855A1 (en) | 2011-05-26 |
| WO2011061332A1 (en) | 2011-05-26 |
| KR20120104262A (en) | 2012-09-20 |
| JP5707009B2 (en) | 2015-04-22 |
| JP2013511496A (en) | 2013-04-04 |
| US20120238639A1 (en) | 2012-09-20 |
| EP2332525A1 (en) | 2011-06-15 |
| AU2010320823A1 (en) | 2012-07-12 |
| MX2012005881A (en) | 2012-06-19 |
| CN102753159B (en) | 2014-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN03130A (en) | ||
| MX2013001677A (en) | Stable formulations of linaclotide. | |
| BR112014009087A2 (en) | xylitol stabilized etanercept formulations | |
| WO2011041729A3 (en) | Compounds as lysophosphatidic acid receptor antagonists | |
| WO2011017350A3 (en) | Compounds as lysophosphatidic acid receptor antagonists | |
| WO2011041461A3 (en) | Polycyclic compounds as lysophosphatidic acid receptor antagonists | |
| EA201290982A1 (en) | PHARMACEUTICAL COMPOSITIONS, PREVENTING ABUSE | |
| BR112012012081A2 (en) | method for processing a kobit medical image file in a protocol-guided imaging procedure, equipment for processing a medical image file obtained by a protocol-guided imaging procedure and computer program design containing instruction sets | |
| PH12013501136A1 (en) | Lysophosphatidic acid receptor antagonists and uses thereof | |
| ZA200809864B (en) | Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic | |
| MX2011011428A (en) | Sulfamoyl benzoic acid derivatives as trpm8 antagonists. | |
| MX2012001660A (en) | Linaclotide-containing formulations for oral administration. | |
| PH12012500754A1 (en) | Pharmaceutical composition comprising oligopeptides | |
| EA201590805A1 (en) | COMPOSITION WITH IMMEDIATE AND PROLONGED DELIVERY | |
| WO2010021607A3 (en) | Pharmaceutical formulation | |
| WO2011157722A3 (en) | Solid ivabradine-containing composition | |
| MY168212A (en) | A new therapeutical composition containing apomorphine as active ingredient | |
| EP3228311A3 (en) | Pharmaceutical and nutraceutical compositions of abscisic acid | |
| WO2013134534A3 (en) | Solid state forms of cabazitaxel and processes for preparation thereof | |
| WO2011069037A3 (en) | Stabilization and storage of biological pharmaceutical compositions | |
| WO2010049449A3 (en) | Novel salts of sunitinib | |
| UA110979C2 (en) | Liquid pharmaceutical formulation comprising nitisinone | |
| MX2010004899A (en) | Novel neurturin conjugates for pharmaceutical use. | |
| EA201200485A1 (en) | ORAL FALLING PHARMACEUTICAL DRUG FORM CONTAINING AIPIPRAZOL | |
| WO2013114400A3 (en) | Compressed pharmaceutical compositions of atypical antipsychotics |